• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Franklin Strategic Series - Franklin Biotechnology Discovery Fund

+ Add to Watchlist

FBDIX:US

126.11 USD 2.79 2.26%

As of 19:59:59 ET on 04/16/2014.

Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)

Year To Date: -3.76% 3-Month: -13.18% 3-Year: +27.29% 52-Week Range: 94.58 - 162.37
1-Month: -17.14% 1-Year: +31.93% 5-Year: +25.13% Beta vs SPX: 1.06

Mutual Fund Chart for FBDIX

No chart data available.
  • FBDIX:US 126.11
  • 1M
  • 1Y
Interactive FBDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBDIX

Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.

Inception Date: 09-15-1997 Telephone: 1-800-632-2301
Managers: EVAN MCCULLOCH / JEREL BANKS
Web Site: www.franklintempleton.com

Fundamentals for FBDIX

NAV (on 2014-04-16) 126.11
Assets (M) (on 2014-02-28) 1,495.04
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for FBDIX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2013-12-16) 1.58
Dividend Yield (ttm) 6.97

Fees & Expenses for FBDIX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.50
Redemption Fee 0.00
12b1 Fee 0.29
Expense Ratio 1.21

Top Fund Holdings for FBDIX

Filing Date: 12/31/2013
Name Position Value % of Total
Gilead Sciences Inc 1,610,700 121,044,105 9.937%
Celgene Corp 702,700 118,728,192 9.747%
Biogen Idec Inc 294,961 82,515,340 6.774%
Amgen Inc 663,300 75,722,328 6.217%
Medivation Inc 782,754 49,955,360 4.101%
Regeneron Pharmaceuticals Inc 170,009 46,793,277 3.842%
Alexion Pharmaceuticals Inc 330,400 43,963,024 3.609%
Incyte Corp Ltd 729,200 36,919,396 3.031%
Vertex Pharmaceuticals Inc 479,600 35,634,280 2.925%
BioMarin Pharmaceutical Inc 452,256 31,780,029 2.609%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil